Specific RNA–protein interactions in the replication of foamy viruses (FVs)

Linial, 2005, Retroviridae, 421 Rethwilm, 2013, Foamy viruses Cullen, 2003, Nuclear RNA export, J Cell Sci, 116, 587, 10.1242/jcs.00268 Pasquinelli, 1997, The constitutive transport element (CTE) of Mason-Pfizer monkey virus (MPMV) accesses a cellular mRNA export pathway, EMBO J, 16, 7500, 10.1093/emboj/16.24.7500 Hofacre, 2009, Jaagsiekte sheep retrovirus encodes a regulatory factor, Rej, required for synthesis of Gag protein, J Virol, 83, 12483, 10.1128/JVI.01747-08 Cullen, 1991, Human immunodeficiency virus as a prototypic complex retrovirus, J Virol, 65, 1053, 10.1128/JVI.65.3.1053-1056.1991 Kang, 1998, Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter, J Virol, 72, 504, 10.1128/JVI.72.1.504-511.1998 Yu, 1996, Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses, Science, 271, 1579, 10.1126/science.271.5255.1579 Bodem, 2011, Foamy virus nuclear RNA export is distinct from that of other retroviruses, J Virol, 85, 2333, 10.1128/JVI.01518-10 Meisner, 2010, Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression, Adv Exp Med Biol, 700, 106, 10.1007/978-1-4419-7823-3_10 Hinman, 2008, Diverse molecular functions of Hu proteins, Cell Mol Life Sci, 65, 3168, 10.1007/s00018-008-8252-6 Breloer, 2008, CD83 regulates lymphocyte maturation, activation and homeostasis, Trends Immunol, 29, 186, 10.1016/j.it.2008.01.009 Prechtel, 2007, CD83: an update on functions and prospects of the maturation marker of dendritic cells, Arch Dermatol Res, 299, 59, 10.1007/s00403-007-0743-z Mou, 2012, HuR posttranscriptionally regulates early growth response-1 (Egr-1) expression at the early stage of T cell activation, FEBS Lett, 586, 4319, 10.1016/j.febslet.2012.10.040 Kummer, 2007, Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome, J Virol, 81, 6326, 10.1128/JVI.02327-06 Senechal, 2004, Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83, Blood, 103, 4207, 10.1182/blood-2003-12-4350 Kruse, 2000, Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA, J Exp Med, 191, 1581, 10.1084/jem.191.9.1581 Pieper, 2011, Functional characterization of the HuR:CD83 mRNA interaction, PLoS ONE, 6, e23290, 10.1371/journal.pone.0023290 Fries, 2007, Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression, J Biol Chem, 282, 4504, 10.1074/jbc.M608849200 Prechtel, 2006, Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element, J Biol Chem, 281, 10912, 10.1074/jbc.M510306200 Srikantan, 2012, Functional interplay between RNA-binding protein HuR and microRNAs, Curr Protein Pept Sci, 13, 372, 10.2174/138920312801619394 Sokoloski, 2010, Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells, Cell Host Microbe, 8, 196, 10.1016/j.chom.2010.07.003 Nadar, 2011, HuR binding to AU-rich elements present in the 3′ untranslated region of Classical swine fever virus, Virol J, 8, 340, 10.1186/1743-422X-8-340 Spangberg, 2000, HuR, a protein implicated in oncogene and growth factor mRNA decay, binds to the 3′ ends of hepatitis C virus RNA of both polarities, Virology, 274, 378, 10.1006/viro.2000.0461 Lin, 2007, Analysis of the interaction of primate retroviruses with the human RNA interference machinery, J Virol, 81, 12218, 10.1128/JVI.01390-07 Whisnant, 2013, In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms, MBio, 4, e000193, 10.1128/mBio.00193-13 Klase, 2012, MicroRNAs and HIV-1: complex interactions, J Biol Chem, 287, 40884, 10.1074/jbc.R112.415448 Baltimore, 1971, Expression of animal virus genomes, Bacteriol Rev, 35, 235, 10.1128/MMBR.35.3.235-241.1971 Lorgeoux, 2012, From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication, Retrovirology, 9, 79, 10.1186/1742-4690-9-79 Li, 2011, A central role for RNA in the induction and biological activities of type 1 interferons, Wiley Interdiscip Rev RNA, 2, 58, 10.1002/wrna.32 Rua, 2012, Innate sensing of foamy viruses by human hematopoietic cells, J Virol, 86, 909, 10.1128/JVI.06235-11 Liberatore, 2011, Sensing retroviruses, Immunity, 35, 8, 10.1016/j.immuni.2011.07.004 Kawai, 2008, Toll-like receptor and RIG-I-like receptor signaling, Ann N Y Acad Sci, 1143, 1, 10.1196/annals.1443.020 Berg, 2012, Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA, PLOS ONE, 7, e29291, 10.1371/journal.pone.0029291 Yu, 2011, The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome, PLoS Pathog, 7, e1002303, 10.1371/journal.ppat.1002303 Hütter, 2013, Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry, J Virol, 87, 3163, 10.1128/JVI.02323-12 Goff, 2013, Retroviridae, 1424 Schliephake, 1994, Nuclear localization of foamy virus Gag precursor protein, J Virol, 68, 4946, 10.1128/JVI.68.8.4946-4954.1994 Müllers, 2011, Novel functions of prototype foamy virus Gag glycine–arginine-rich boxes in reverse transcription and particle morphogenesis, J Virol, 85, 1452, 10.1128/JVI.01731-10 Yu, 1996, The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains, J Virol, 70, 8255, 10.1128/JVI.70.12.8255-8262.1996 Heinkelein, 1998, Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors, J Virol, 72, 6307, 10.1128/JVI.72.8.6307-6314.1998 Huang, 1997, Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein, J Virol, 71, 4472, 10.1128/JVI.71.6.4472-4478.1997 Enssle, 1996, Foamy virus reverse transcriptase is expressed independently from the Gag protein, Proc Natl Acad Sci U S A, 93, 4137, 10.1073/pnas.93.9.4137 Löchelt, 1996, The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein, J Virol, 70, 1033, 10.1128/JVI.70.2.1033-1040.1996 Swiersy, 2011, Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication, Retrovirology, 8, 66, 10.1186/1742-4690-8-66 Spannaus, 2012, The prototype foamy virus protease is active independently of the integrase domain, Retrovirology, 9, 41, 10.1186/1742-4690-9-41 Lee, 2012, Foamy virus Pol protein expressed as a Gag-Pol fusion retains enzymatic activities, allowing for infectious virus production, J Virol, 86, 5992, 10.1128/JVI.06979-11 Park, 1991, Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production, J Virol, 65, 5111, 10.1128/JVI.65.9.5111-5117.1991 Heinkelein, 2002, Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids, J Virol, 76, 10069, 10.1128/JVI.76.19.10069-10073.2002 Peters, 2005, RNA and protein requirements for incorporation of the Pol protein into foamy virus particles, J Virol, 79, 7005, 10.1128/JVI.79.11.7005-7013.2005 Wiktorowicz, 2009, Generation of an improved foamy virus vector by dissection of cis-acting sequences, J Gen Virol, 90, 481, 10.1099/vir.0.006312-0 Lee, 2013, Foamy virus assembly with emphasis on pol encapsidation, Viruses, 5, 886, 10.3390/v5030886 Hartl, 2010, Formation of transient dimers by a retroviral protease, Biochem J, 427, 197, 10.1042/BJ20091451 Hartl, 2010, Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases, Retrovirology, 7, 5, 10.1186/1742-4690-7-5 Kupiec, 1988, Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses, Nucleic Acids Res, 16, 9557, 10.1093/nar/16.20.9557 Tobaly-Tapiero, 1991, Further characterization of the gapped DNA intermediates of human spumavirus: evidence for a dual initiation of plus-strand DNA synthesis, J Gen Virol, 72, 605, 10.1099/0022-1317-72-3-605 Peters, 2008, Complex effects of foamy virus central purine-rich regions on viral replication, Virology, 373, 51, 10.1016/j.virol.2007.10.037 Hartl, 2011, Regulation of foamy virus protease activity by viral RNA — a novel and unique mechanism among retroviruses, J Virol, 85, 4462, 10.1128/JVI.02211-10 Cartellieri, 2005, Determination of the relative amounts of Gag and Pol proteins in foamy virus particles, Retrovirology, 2, 44, 10.1186/1742-4690-2-44 Rinke, 2002, Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity, J Virol, 76, 7560, 10.1128/JVI.76.15.7560-7570.2002 Moebes, 1997, Human foamy virus reverse transcription that occurs late in the viral replication cycle, J Virol, 71, 7305, 10.1128/JVI.71.10.7305-7311.1997 Roy, 2003, Feline foamy virus genome and replication strategy, J Virol, 77, 11324, 10.1128/JVI.77.21.11324-11331.2003 Yu, 1999, Evidence that the human foamy virus genome is DNA, J Virol, 73, 1565, 10.1128/JVI.73.2.1565-1572.1999 Matthes, 2011, Basic residues in the foamy virus gag protein, J Virol, 85, 3986, 10.1128/JVI.01906-10 Darlix, 2000, Nucleocapsid protein of human immunodeficiency virus as a model protein with chaperoning functions and as a target for antiviral drugs, Adv Pharmacol, 48, 345, 10.1016/S1054-3589(00)48011-7 Levin, 2005, Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism, Prog Nucleic Acid Res Mol Biol, 80, 217, 10.1016/S0079-6603(05)80006-6 Spannaus, 2013, Foamy viral Gag p71/p68 cleavage is required for template switch of the reverse transcriptase, J Virol, 10.1128/JVI.00833-13 Houzet, 2008, Nucleocapsid mutations turn HIV-1 into a DNA-containing virus, Nucleic Acids Res, 26, 2311, 10.1093/nar/gkn069 Mannigel, 2007, Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome, J Virol, 81, 3317, 10.1128/JVI.01866-06 Enssle, 1997, Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle, J Virol, 71, 7312, 10.1128/JVI.71.10.7312-7317.1997 Delelis, 2003, Biphasic DNA synthesis in spumaviruses, J Virol, 77, 8141, 10.1128/JVI.77.14.8141-8146.2003 Zamborlini, 2010, Early reverse transcription is essential for productive foamy virus infection, PLoS ONE, 5, e11023, 10.1371/journal.pone.0011023 Jackson, 2013, Expression of prototype foamy virus pol as a Gag-Pol fusion protein does not change the timing of reverse transcription, J Virol, 87, 1252, 10.1128/JVI.02153-12 Schrom, 2013, U1snRNP-mediated suppression of polyadenylation in conjunction with the RNA structure controls poly (A) site selection in foamy viruses, Retrovirology, 10, 55, 10.1186/1742-4690-10-55 Schepetilnikov, 2009, Molecular dissection of the prototype foamy virus (PFV) RNA 5’-UTR identifies essential elements of a ribosomal shunt, Nucleic Acids Res, 37, 5838, 10.1093/nar/gkp609 Löchelt, 2005, The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein, Proc Natl Acad Sci U S A, 102, 7982, 10.1073/pnas.0501445102 Heinkelein, 2002, Improved primate foamy virus vectors and packaging constructs, J Virol, 76, 3774, 10.1128/JVI.76.8.3774-3783.2002